Biology:COMPLi

COMPLi is a first-of-its kind compliance platform that was launched by Scientist.com in collaboration with the top 25 pharmaceutical companies, contract research organizations (CROs) and biobanks in 2017.^1,2

History

As global policies on the provision of biological specimens used for research are not aligned and can be difficult to adhere to for a global pharmaceutical company,  COMPLi was launched in order to improve compliance, oversight and governance through proactive collection of information coupled with bespoke contracts and enhanced compliance tools.³ COMPLi ultimately reduces the administrative burden and inherent risks pharmaceutical companies, biotechs and academic labs face when sourcing regulated services and materials from external third parties.⁴

In 2018, COMPLi received the Excellence in Pharma: Regulatory and Compliance Framework award at the 2018 CPhI Pharma Awards.⁵ By 2019, Scientist.com added animal welfare, secondary real-world evidence (RWE), health economics and outcomes research (HEOR), and GxP services to the COMPLi functionality.⁶ In 2020, Scientist.com partnered with UK biobanks and large pharmaceutical companies to see how COMPLi could help solve challenges biobanks face when working with industry partners.⁷  Later in 2020, Scientist.com launched the COMPLi HBS Legislation Series, an ongoing educational webinar series intended to inform researchers of the varying regulations governing biological specimen acquisition globally.^8,9,10,11 By the end of 2020, Scientist.com expanded COMPLi to include VERIF.i, a supplier pre-assessment program designed with input from multiple large pharmaceutical companies to enable proactive pre-assessments of suppliers in various higher risk areas such as biological specimen provision, animal welfare and Chemistry Manufacturing and Controls (CMC).¹²

In 2021, Scientist.com partnered with Enhancing Quality in Preclinical Data (EQIPD) to better monitor and enhance the role that preclinical quality certifications can play in fostering biopharma-CRO relationships—through COMPLi, a preclinical service provider can now self-certify against the EQIPD standard and promote this to organizations to increase confidence in the quality of data being generated through